首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1510410

蛋白質檢測市場規模、佔有率、成長分析、按應用、按檢測技術、按產品類型、按最終用戶、按地區 - 行業預測，2024-2031 年

Protein Assays Market Size, Share, Growth Analysis, By Application, By Detection Technology, By Product Type(Instruments, Assay Kits ), By End-User, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月03日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年蛋白質檢測市場規模將為21.8億美元，預測期內（2024-2031年）複合年成長率為10.4%，從2023年的24.1億美元增至2031年的53億美元。美元百萬。

由於各種因素，蛋白質檢測市場正在顯著成長。生物技術和生命科學的進步，以及對蛋白質組學研究和藥物發現的日益關注，正在推動對蛋白質檢測的需求。此外，慢性病的增加和精確診斷的需求也促進了市場的擴張。高通量篩檢方法等技術進步提高了蛋白質定量的效率。然而，與測定複雜性和蛋白質系統變異性相關的挑戰是其限制。北美由於其強大的研究基礎設施和製藥進步而佔據了重要的市場佔有率。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
Merck KGaA（Germany）
Agilent Technologies, Inc.（United States）
Abcam plc（United Kingdom）
PerkinElmer, Inc.（United States）
Promega Corporation（United States）
Takara Bio Inc.（Japan）
Bio-Techne Corporation（United States）
GE Healthcare Life Sciences（United Kingdom）
Lonza Group Ltd.（Switzerland）
Qiagen NV（Netherlands）
Becton, Dickinson and Company（United States）
Enzo Biochem, Inc.（United States）
Cell Signaling Technology, Inc.（United States）
Bruker Corporation（United States）
New England Biolabs, Inc.（United States）
Cytiva（United States）
Luminex Corporation（United States）
Sigma-Aldrich Co. LLC（United States）

簡介目錄

Product Code: SQMIG35D2203

Protein Assays Market size was valued at USD 2.18 billion in 2022 and is poised to grow from USD 2.41 billion in 2023 to USD 5.31 billion by 2031, at a CAGR of 10.4% during the forecast period (2024-2031).

The Protein Assays market experiences substantial growth due to various factors. Increased focus on proteomics research and drug discovery, alongside advancements in biotechnology and life sciences, drives demand for protein assays. Additionally, rising incidences of chronic diseases and the need for precise diagnostics further contribute to market expansion. Technological advancements such as high-throughput screening methods enhance the efficiency of protein quantification. However, challenges related to assay complexity and variability in protein systems present constraints. North America commands a significant market share, owing to robust research infrastructure and advancements in pharmaceuticals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Assays Market Segmental Analysis

The global apoptosis assays market is segmented based on product type, detection technology, application, end-user, and region. By product, the market is segmented into Instruments, Assay Kits (Caspase Assays, Annexin V and Cell Permeability Assays, DNA Fragmentation Assays, Mitochondrial Assays), Reagents, Microplates. Based on Detection Technology, the market is segmented into Flow Cytometry, Cell Imaging and Microscopy, Spectrophotometry, and Others. By Application, the market is segmented into Drug Discovery and Development, Clinical and Diagnostic Applications, Basic Research, Stem Cell Research. By end-user, the market is segmented into pharmaceutical & biotechnology companies, hospital & diagnostic laboratories, and academic & research institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Drivers of the Protein Assays Market

The growing focus on proteomics research and drug discovery drives the demand for precise and efficient methods of protein quantification. As the pharmaceutical and biotechnology industries continue to expand, the necessity for dependable protein assays to evaluate drug effectiveness and safety becomes increasingly critical.

Restraints in the Protein Assays Market

One of the primary market challenges is the difficulty in standardizing assays and dealing with variability in protein structures, which hinder achieving universally applicable and accurate quantification. The complexity of certain assays may also limit their widespread adoption, especially in environments where simplicity and rapid results are crucial.

Market Trends of the Protein Assays Market

There has been a significant increase in the development of high-throughput and multiplexed assay systems, allowing simultaneous analysis of multiple proteins. This trend corresponds with the rising demand for efficiency and comprehensive protein profiling across diverse research and clinical applications. Additionally, the introduction of modern technologies such as microfluidics and biosensors is driving innovation in protein assay methodologies, offering enhanced sensitivity and reduced sample volumes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Value Chain Analysis
Patent Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Protein Assays Market by Type

Market Overview
Dye-Binding Assays
Test Strip-Based Assays
Copper-Ion-Based Assays
Bradford Protein Assays
Others

Protein Assays Market by Product

Market Overview
Kits
Reagents
Instruments & Accessories

Protein Assays Market by Technology

Market Overview
Fluorometric Assays
Colorimetric Assays
Chemiluminescent Assays

Protein Assays Market by Application

Market Overview
Drug Discovery & Development
Disease Diagnosis
Others

Protein Assays Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Clinical Laboratories
Hospitals
Academic Research Institutes
Others

Protein Assays Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare Life Sciences (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytiva (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Co. LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments